Article · 7 Oct 2025
Research articlePublished 14 Nov 2015
TO STUDY THE SAFETY AND EFFECTIVENESS OF PHOTOTHERAPY, PHOTOTHERAPY PLUS PHENOBARBITONE IN NEONATAL HYPERBILIRUBENEMIA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
ABSTRACT: INTRODUCTION AND BACKGROUND: Neonatal hyperbilirubenemia is increased levels of bilirubin in the blood of neonates and it is an important cause of morbidity in the developing world. AIM: The study aims to assess and compare the safety as well as efficacy of Phototherapy alone and Phototherapy plus Phenobarbitone in neonatal hyperbilirubenemia. METHODOLOGY: This is a prospective observational study which was conducted in NICU of Government General Hospital, Anantapur. The study was carried out to assess the safety and efficacy of Group–A (Phototherapy alone) and Group–B (Phototherapy plus Phenobarbitone) in Neonatal hyperbilirubenemia. In both treatment A and treatment B groups, baseline characteristics were recorded and matched with each, later subjects are evaluated for outcome measures (Peak serum bilirubin levels, duration of phototherapy in hours), need of phototherapy and adverse drug effects) and safety measures (ADR profiles for Phototherapy as well as Phototherapy plus Phenobarbitone). All clinical outcome measures compared with each other by using paired T test to select best treatment option for clinical practice. RESULTS: There was no significant difference between Phototherapy as well as Phototherapy plus Phenobarbitone group in case of total, direct serum bilirubin levels before and after treatment as well as there is no difference in duration of phototherapy (24hrs,48hrs,72hrs) and for all remaining characteristics we calculated in terms of percentage, mean and standard deviation. The P value has no significance (>0.05) DISCUSSION: The neonates who have been Treated with Phenobarbitone had shown clinical features like Drowsiness and Dehydration with were been corrected by IV fluids and Artificial mother feed. Mono therapy (phototherapy) is alone sufficient when compared to the combination therapy (in treating cases with phototherapy plus Phenobarbitone). In the present study, no significant side effect of phototherapy was observed, and phototherapy was effective in decreasing bilirubin levels in both groups. CONCLUSION: Combination of phototherapy with Phenobarbitone did not produce any difference in bilirubin levels when compared to phototherapy alone throughout 72 hrs. But when safety profile is considered Phototherapy is best option, because Phenobarbitone has toxic ADR profile when compared with phototherapy alone.
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Evidence-Based Medicine and Healthcare.
Article · 28 Jul 2025
Association between Admission Blood Pressure, Stroke Severity and Early Outcome in Thrombolysed Ischemic Stroke Patients: A Single Centre Experience from Northeast India
Article · 28 Mar 2025
Isolated Paralysis of Extensor Indicis and EDC Tendon of Index Finger Following Thompsonandrsquo;s Approach to Proximal Radius-Case Report
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Evidence-Based Medicine and Healthcare
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Malleswari”
- BylineArticles whose byline prints “P. Ravi Kumar”
- BylineArticles whose byline prints “B. Sasi Kumar”
- BylineArticles whose byline prints “Muchukota Sushma”